Braveheart Bio (BRVE) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Braveheart Bio insider trading at a glance (Oct 9, 2026): in the past 12 months, 10 insiders bought $159M and 0 sold $0 of BRVE stock on the open market, including a cluster buy that began Aug 7, 2026.
Get emailed when insiders cluster-buy stocks like BRVE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BRVE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $159M | 13 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 10 Braveheart Bio, Inc. insiders reported open-market purchases totaling $159M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Aug 7, 2026, when 10 insiders bought a combined $159M.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 11SEC | Erez ChimovitsDirector | Buy | 1,666,66711,901,826 held (+16%) | $18.00 | $30.0M | +11.2% | — |
| Aug 11SEC | Orbimed Genesis Gp LlcDirector | Buy | 1,666,66711,901,826 held (+16%) | $18.00 | $30.0M | +11.2% | — |
| Aug 11SEC | Marc L Andreessen10% Owner | Buy | 1,100,00010,232,420 held (+12%) | $18.00 | $19.8M | +11.2% | — |
| Aug 11SEC | Erez ChimovitsDirector | Buy | 273,333new position | $18.00 | $4.9M | +11.2% | — |
| Aug 11SEC | Orbimed Genesis Gp LlcDirector | Buy | 273,333new position | $18.00 | $4.9M | +11.2% | — |
| Aug 7SEC | Forbion Growth Opportunities Fund Iii Cooperatief U.A.10% Owner | Buy | 1,920,00011,640,546 held (+20%) | $18.00 | $34.6M | +11.2% | — |
| Aug 7SEC | Forbion Growth Opportunities Fund Iii Cooperatief U.A.10% Owner | Buy | 1,680,00010,185,478 held (+20%) | $18.00 | $30.2M | +11.2% | — |
| Aug 7SEC | Travis MurdochCEO, President | Buy | 83,3332,940,670 held (+3%) | $18.00 | $1.5M | +11.2% | — |
| Aug 7SEC | Christopher ViehbacherDirector | Buy | 83,333609,519 held (+16%) | $18.00 | $1.5M | +11.2% | — |
| Aug 7SEC | David Charles LubnerDirector | Buy | 55,555new position | $18.00 | $1000K | +11.2% | — |
| Aug 7SEC | James Paul RickeyCFO | Buy | 27,777520,927 held (+6%) | $18.00 | $500K | +11.2% | — |
| Aug 7SEC | David I MalekDirector | Buy | 4,166533,845 held (+1%) | $18.00 | $75K | +11.2% | — |
| Aug 7SEC | Michele A. AndersonChief Development Officer | Buy | 1,111332,161 held (+0%) | $18.00 | $20K | +11.2% | — |
Insiders at Braveheart Bio, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Forbion Growth Opportunities Fund Iii Cooperatief U.A.10% Owner | $64.8M | — | Aug 7, 2026 | — |
| Erez ChimovitsDirector | $34.9M | — | Aug 11, 2026 | — |
| Orbimed Genesis Gp LlcDirector | $34.9M | — | Aug 11, 2026 | — |
| Marc L Andreessen10% Owner | $19.8M | — | Aug 11, 2026 | — |
| Travis MurdochCEO, President | $1.5M | — | Aug 7, 2026 | — |
| Christopher ViehbacherDirector | $1.5M | — | Aug 7, 2026 | — |
| David Charles LubnerDirector | $1000K | — | Aug 7, 2026 | — |
| James Paul RickeyCFO | $500K | — | Aug 7, 2026 | — |
| David I MalekDirector | $75K | — | Aug 7, 2026 | — |
| Michele A. AndersonChief Development Officer | $20K | — | Aug 7, 2026 | — |
BRVE stock: common questions
Are Braveheart Bio, Inc. insiders buying BRVE stock?
In the past 12 months, 10 insiders reported open-market purchases of BRVE worth $159M. The latest was Director Erez Chimovits bought $30.0M of BRVE at $18.00 — first open-market purchase in our records.
Are Braveheart Bio, Inc. insiders selling BRVE stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BRVE's 52-week range?
Over the past year BRVE has traded between $18.58 and $30.00. It last closed at $20.02 on Oct 9, 2026.